Novlead is a medical device development company that engages in the research and development and production of new medical devices. It builds a diversified molecular technology platform for immediate generation and sustained release of nitric oxide (NO), and provides new solutions for major clinical pain points in the medical fields such as cardiopulmonary, respiratory, and anti-infection. The company was founded in 2018 and is based in Nanjing, China.
Novlead Frequently Asked Questions (FAQ)
When was Novlead founded?
Novlead was founded in 2018.
Where is Novlead's headquarters?
Novlead's headquarters is located at No. 73, Tanmi Road, Nanjing.
What is Novlead's latest funding round?
Novlead's latest funding round is Series B - II.
How much did Novlead raise?
Novlead raised a total of $18.81M.
Who are the investors of Novlead?
Investors of Novlead include Lilly Asia Ventures, 3E Bioventures, Co-Stone Venture Capital, Jianyuan Tianhua, Jin Yuan Capital and 4 more.